Clinical Trial Update: Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and tolerability of GBT440 in IPF patients has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxemia
• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• GBT440

Snippet

Sponsor: Global Blood Therapeutics | Conditions: Idiopathic Pulmonary Fibrosis, Hypoxemia | Phase 2 | Status: COMPLETED | Results posted: 2020-09-22